TRELZAPH Trademark

Trademark Overview

On Thursday, January 15, 2009, a trademark application was filed for TRELZAPH with the United States Patent and Trademark Office. The USPTO has given the TRELZAPH trademark a serial number of 77650521. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 11, 2013. This trademark is owned by Glaxo Group Limited. The TRELZAPH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
trelzaph

General Information

Serial Number77650521
Word MarkTRELZAPH
Filing DateThursday, January 15, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 11, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 20, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 21, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 11, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 11, 2013ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 11, 2012EXTENSION 5 GRANTED
Tuesday, July 3, 2012EXTENSION 5 FILED
Tuesday, July 3, 2012TEAS EXTENSION RECEIVED
Saturday, January 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 13, 2012EXTENSION 4 GRANTED
Thursday, January 5, 2012EXTENSION 4 FILED
Thursday, January 5, 2012TEAS EXTENSION RECEIVED
Saturday, June 25, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 24, 2011EXTENSION 3 GRANTED
Wednesday, June 22, 2011EXTENSION 3 FILED
Wednesday, June 22, 2011TEAS EXTENSION RECEIVED
Tuesday, December 14, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 13, 2010EXTENSION 2 GRANTED
Wednesday, November 24, 2010EXTENSION 2 FILED
Wednesday, November 24, 2010TEAS EXTENSION RECEIVED
Wednesday, August 4, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 3, 2010EXTENSION 1 GRANTED
Friday, July 2, 2010EXTENSION 1 FILED
Monday, August 2, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 2, 2010TEAS EXTENSION RECEIVED
Friday, May 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 12, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2009PUBLISHED FOR OPPOSITION
Thursday, September 17, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 12, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Saturday, September 12, 2009ASSIGNED TO LIE
Friday, September 4, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 4, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 4, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 6, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 6, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 12, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009LETTER OF SUSPENSION E-MAILED
Thursday, March 12, 2009SUSPENSION LETTER WRITTEN
Wednesday, March 11, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

trelzaph pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic